Kenya’s One Health AMR Network Expanded From Pilot Fragmentation to National Coordination
Kenya’s antimicrobial resistance surveillance effort has moved well beyond its early pilot phase. In 2018, the system was still fragmented, with limited site coverage and uneven coordination across human, animal, and environmental health. By 2025, surveillance had expanded to 30 sites across those three sectors, turning antimicrobial resistance monitoring into a far more integrated national function.
The change was not only geographic. National reporting began to combine AMR data with antimicrobial consumption and antimicrobial use information, giving decision-makers a more complete picture of how resistance emerges and spreads. For a country building a One Health framework, that shift matters because resistance does not respect sector boundaries. Patterns in human hospitals, livestock production, and environmental contamination can reinforce one another, and a surveillance system that tracks only one of those domains risks missing the biological and operational drivers of resistance.
Surveillance Growth Translated Into Usable Public Health Intelligence
The most consequential advance was not simply the increase in site count. Routine reporting matured enough to feed global platforms, while domestic outputs such as dashboards, reports, and policy briefs became part of the decision-making chain. Those products informed antimicrobial stewardship, Infection Prevention and Control, regulatory action, and broader policy choices. In practical terms, surveillance stopped being a passive recordkeeping exercise and became an instrument for action.
A surveillance network earns its value when the data move. Here, the programmatic emphasis shifted toward routine interpretation and use, which is often the point where surveillance systems in low- and middle-income settings stall. Laboratory results alone do not alter prescribing, farm practice, or environmental controls unless governance structures are strong enough to translate findings into policy and operational response. Kenya’s experience shows how a surveillance platform can mature when reporting pathways, technical infrastructure, and government ownership advance together.
Governance, Coordination, and Partner Support Shaped the Program’s Trajectory
The program’s progress rested on more than laboratory expansion. Governance across the One Health sectors evolved, and implementation became more coordinated over time. That coordination appears to have been critical in moving from isolated activities toward a nationally coherent surveillance architecture. External support from the Fleming Fund helped accelerate development, but the report’s central message is that durable progress depended on embedding surveillance within government-led structures rather than keeping it as a donor-dependent pilot.
This distinction is clinically and operationally important. AMR surveillance requires recurring specimen collection, laboratory capacity, data validation, reporting discipline, and feedback loops to clinicians, veterinarians, regulators, and policymakers. If any one of those pieces is weak, the system produces information that is late, incomplete, or disconnected from action. Kenya’s evolution suggests that multi-sector surveillance can be built, but only when institutions are organized to absorb the work year after year.
External Benchmarks Showed Movement Toward Demonstrated Capacity
Independent benchmarking suggested the system was strengthening. World Health Organization Joint External Evaluation scores improved from limited to demonstrated capacity for surveillance and multisectoral coordination. Those scores do not by themselves measure reductions in resistant infections or better patient outcomes, but they do indicate that core systems became more reliable and more mature.
The improvement is meaningful because AMR surveillance is only as strong as the infrastructure beneath it. Laboratories need consistent quality assurance. Data systems need harmonized definitions and reporting pathways. Sectors need common governance mechanisms so that a resistance signal in one domain can trigger review in another. Kenya’s gains imply that those foundations became more stable between 2018 and 2025, even though the system still faces important sustainability questions.
Why Routine Data Use Matters More Than Data Accumulation
The report places unusual weight on routine data use, and for good reason. Surveillance systems can accumulate reports for years without influencing practice. In AMR, that failure has direct bedside consequences: resistant infections continue unchecked, empiric therapy drifts away from local susceptibility patterns, and stewardship interventions lose precision. The value of surveillance lies in whether the data are visible, timely, and credible enough to shape prescribing and containment strategies.
Kenya’s outputs, including dashboards and policy briefs, suggest that the program moved closer to that standard. When antimicrobial consumption and antimicrobial use data sit alongside resistance findings, the resulting picture becomes more actionable for human health services, veterinary oversight, and regulatory authorities. That integrated view can identify overuse patterns, spot sector-specific drivers of resistance, and inform targeted interventions rather than broad, untethered recommendations.
Predictable Financing Will Determine Whether the Gains Hold
The report’s final message is blunt: progress depends on government-led governance, technical systems, and coordinated partner support, but sustaining the gains will require predictable financing and routine data use. That is the central vulnerability in many surveillance programs. Expansion is easier than maintenance, and donor-supported gains can fade when recurrent costs are not absorbed into national budgets.
Kenya’s experience offers a realistic template for other low- and middle-income settings trying to operationalize One Health AMR surveillance. The country showed that fragmented pilot activity can be consolidated into a multisectoral system with broader reporting, better coordination, and stronger external benchmark scores. The unresolved issue is endurance. Maintaining 30 surveillance sites, keeping reporting routines active, and ensuring that data continue to influence stewardship and policy will require steady financing, institutional commitment, and continued cross-sector alignment rather than episodic support.